These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 25472810

  • 1. Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
    Sakurada Y, Nakamura Y, Yoneyama S, Mabuchi F, Gotoh T, Tateno Y, Sugiyama A, Kubota T, Iijima H.
    Ophthalmic Res; 2015; 53(1):2-7. PubMed ID: 25472810
    [Abstract] [Full Text] [Related]

  • 2. Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients.
    Zhou H, Zhao X, Yuan M, Chen Y.
    BMC Ophthalmol; 2020 Jan 08; 20(1):15. PubMed ID: 31914968
    [Abstract] [Full Text] [Related]

  • 3. Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.
    Agawa T, Usui Y, Wakabayashi Y, Okunuki Y, Juan M, Umazume K, Kezuka T, Takeuchi M, Yamauchi Y, Goto H.
    Retina; 2014 Sep 08; 34(9):1811-8. PubMed ID: 24801651
    [Abstract] [Full Text] [Related]

  • 4. Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kokame GT, deCarlo TE, Kaneko KN, Omizo JN, Lian R.
    Ophthalmol Retina; 2019 Sep 08; 3(9):744-752. PubMed ID: 31511169
    [Abstract] [Full Text] [Related]

  • 5. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec 08; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 6. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
    Tong JP, Chan WM, Liu DT, Lai TY, Choy KW, Pang CP, Lam DS.
    Am J Ophthalmol; 2006 Mar 08; 141(3):456-62. PubMed ID: 16490490
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy versus combination therapy in polypoidal choroidal vasculopathy: changes of aqueous vascular endothelial growth factor.
    Lee MY, Lee WK, Baek J, Kwon OW, Lee JH.
    Am J Ophthalmol; 2013 Aug 08; 156(2):343-8. PubMed ID: 23664208
    [Abstract] [Full Text] [Related]

  • 8. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
    Ting DS, Ng WY, Ng SR, Tan SP, Yeo IY, Mathur R, Chan CM, Tan AC, Tan GS, Wong TY, Cheung CM.
    Am J Ophthalmol; 2016 Apr 08; 164():128-36.e1. PubMed ID: 26743619
    [Abstract] [Full Text] [Related]

  • 9. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
    dell'Omo R, Cassetta M, dell'Omo E, di Salvatore A, Hughes JM, Aceto F, Porcellini A, Costagliola C.
    Am J Ophthalmol; 2012 Jan 08; 153(1):155-61.e2. PubMed ID: 21861975
    [Abstract] [Full Text] [Related]

  • 10. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration.
    Kikuchi M, Nakamura M, Ishikawa K, Suzuki T, Nishihara H, Yamakoshi T, Nishio K, Taki K, Niwa T, Hamajima N, Terasaki H.
    Ophthalmology; 2007 Sep 08; 114(9):1722-7. PubMed ID: 17400294
    [Abstract] [Full Text] [Related]

  • 11. Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration.
    Muether PS, Hermann MM, Dröge K, Kirchhof B, Fauser S.
    Am J Ophthalmol; 2013 Nov 08; 156(5):989-993.e2. PubMed ID: 23938122
    [Abstract] [Full Text] [Related]

  • 12. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT, Omizo JN, Kokame KA, Yamane ML.
    Ophthalmol Retina; 2021 Oct 08; 5(10):954-961. PubMed ID: 34022443
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of Neovascular Age-Related Macular Degeneration in Brazilian Patients.
    Pereira FB, Veloso CE, Kokame GT, Nehemy MB.
    Ophthalmologica; 2015 Oct 08; 234(4):233-42. PubMed ID: 26394133
    [Abstract] [Full Text] [Related]

  • 14. Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment.
    Yamashiro K, Tomita K, Tsujikawa A, Nakata I, Akagi-Kurashige Y, Miyake M, Ooto S, Tamura H, Yoshimura N.
    Am J Ophthalmol; 2012 Jul 08; 154(1):125-36. PubMed ID: 22465368
    [Abstract] [Full Text] [Related]

  • 15. Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
    Kato Y, Oguchi Y, Omori T, Shintake H, Tomita R, Kasai A, Ogasawara M, Sugano Y, Itagaki K, Ojima A, Machida T, Sekine H, Sekiryu T.
    Invest Ophthalmol Vis Sci; 2020 Nov 02; 61(13):39. PubMed ID: 33252634
    [Abstract] [Full Text] [Related]

  • 16. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration.
    Shin JY, Kwon KY, Byeon SH.
    Acta Ophthalmol; 2015 Sep 02; 93(6):524-32. PubMed ID: 25581639
    [Abstract] [Full Text] [Related]

  • 17. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T.
    Ophthalmology; 2016 Mar 02; 123(3):617-24. PubMed ID: 26686967
    [Abstract] [Full Text] [Related]

  • 18. Dynamics of Inflammatory Factors in Aqueous Humor during Ranibizumab or Aflibercept Treatment for Age-Related Macular Degeneration.
    Motohashi R, Noma H, Yasuda K, Kotake O, Goto H, Shimura M.
    Ophthalmic Res; 2017 Mar 02; 58(4):209-216. PubMed ID: 28796997
    [Abstract] [Full Text] [Related]

  • 19. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H, Ji B, Chung H, Kim HC.
    Retina; 2016 Mar 02; 36(3):465-75. PubMed ID: 26076214
    [Abstract] [Full Text] [Related]

  • 20. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment.
    Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW.
    Retina; 2009 Apr 02; 29(4):523-9. PubMed ID: 19262441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.